G Dávila-Loaiza

Suggest Changes
Learn More
Second-line treatments recommended by the National Cancer Center Network to manage advanced-stage gastrointestinal stromal tumours (GIST) were evaluated to determine the cost and cost-effectiveness(More)
  • 1